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Abstract
Objective: It is unclear whether how people with long-term conditions express distress, and how clinicians
respond, influences perceptions of consultation outcomes. The pilot study examined emotional distress and
reassurance in consultations with people whose long-term conditions (at the time of consultations) were treated
using active surveillance or symptom management (as no curative treatment was suitable).
Methods: An observational pilot study was conducted involving consultations between people with long-term
conditions and their respective clinician. Consultations between three clinicians (two Huntington’s Disease; one
Prostate Cancer) and 22 people with long-term conditions (11 Huntington’s Disease; 11 Prostate Cancer) were
audio-recorded. Participants also completed an expanded Consultation and Relational Empathy (CARE) Measure.
Two researchers coded sessions using Verona Coding Definitions of Emotional Sequences (VR-CoDES/VR-CoDES-P).
Code frequencies were calculated, t tests performed between conditions, and Pearson’s correlations performed for
associations between CARE responses and clinician utterances.
Results: People with long-term conditions expressed emotional distress on average 4.45 times per session,
averaging 1.09 Concern and 3.36 Cue utterances. Clinicians responded with more explicit (2.59) and space-
providing (3.36), than non-explicit (1.86) and space-reducing (1.09), responses per session. Clinicians expressed
spontaneous reassurance on average 5.18 times per session, averaging 3.77 Cognitive and 1.5 Affective reassurance
utterances. Huntington’s Disease consultations featured significantly more 'Cues', 'Concerns' and 'Overall' 'Emotional
Distress', and 'Cognitive' and 'Overall' ‘Reassurance'.
(Continued on next page)
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: NiallCAnderson@outlook.com
School of Medicine, University of St Andrews, St. Andrews KY16 9TF, UK
Anderson et al. Pilot and Feasibility Studies           (2021) 7:119 
https://doi.org/10.1186/s40814-021-00833-z
(Continued from previous page)
Conclusion: Emotional distress was expressed more using hints than explicit concern utterances. Clinicians
predominantly explicitly explored distress rather than providing information/advice and provided advice using
spontaneous cognitive reassurance. People with Huntington’s Disease expressed more concerns and received more
reassurance, indicating different needs between conditions. Future research is required to explore emotional
distress and reassurance in a larger sample of participants and long-term condition types, and how the practical
implications of these findings may be used to enhance outcomes of consultations.
Trial registration: N/A.
Keywords: Affective reassurance, Cognitive reassurance, Emotional distress, Huntington’s disease, Prostate cancer
Key messages regarding feasibility
 What uncertainties existed regarding feasibility?
First, in what frequency and form is emotional distress
expressed by people with long-term conditions, and how
do clinicians respond and provide reassurance, in med-
ical consultations for which curative treatment (at the
time of the consultation) was not available? Second, how
does this relate to people with long-term conditions’
perceptions of consultation outcomes, particularly in
terms of consultation and relational empathy, and per-
ceived satisfaction? Third, are differences present be-
tween different types of long-term health conditions for
which curative treatments are not currently available?
 What are the key feasibility findings?
People with long-term conditions on average
expressed emotional distress 4.45 times per session. Cli-
nicians responded with more explicit (2.59) and space-
providing (3.36), than non-explicit (1.86) and space-
reducing (1.09), utterances. Clinicians expressed spon-
taneous reassurance on average 5.18 times per session
(3.77 Cognitive; 1.5 Affective). Huntington’s disease con-
sultations featured significantly more 'Cues', 'Concerns'
and 'Overall' Emotional Distress, and 'Cognitive' and
'Overall' ‘Reassurance'. Consultations with a higher fre-
quency of cognitive reassurance were associated with
lower ratings of 'Letting you tell your story', ‘Showing
care and compassion', 'Helping you to take control', and
'Making a plan of action with you'.
 What are the implications of the feasibility findings
for the design of the main pilot study?
People with long-term conditions for which no cura-
tive treatment was available (at the time of the pilot
study) demonstrated high levels of emotional distress in
medical consultations, highlighting the need for further
focus on this area within both healthcare research and
intervention. The methodology used allowed for in-
depth assessment of consultation interactions and pro-
vides valuable findings with real-world implications for
healthcare policy, practice and training. Clinicians and
people with long-term conditions for whom no curative
treatment is currently available were highly interested
and engaged in the research process. VR-CoDES and the
CARE measure provided a suitable method for examin-
ing emotional distress, reassurance and how these may
relate to consultation outcomes for consultations involv-
ing people with long-term conditions, and may allow
direct comparisons to be made between conditions.
However, developments in research relating to the inves-
tigation of sequencing of events since the pilot study was




A significant part of a clinician’s role in consultations in-
volves managing concerns and providing reassurance
about emotional distress that may be experienced about
diagnosis, symptoms, treatment, and potential outcomes
[1]. Reassurance is characterised as any clinician behav-
iour conducted to positively impact behaviour, thoughts
or understanding [2]. Emotional distress and responses
to reassurance may vary significantly based on age, per-
ceived symptom discomfort and what this means to the
person, clinicians’ working experience, and the timing
(rather than frequency or duration) of reassurance [3–7].
Critically, the conversational style used by clinicians may
promote different responses and outcomes. Open-ended
questions and space-providing responses are associated
with an Affective style that promotes relationship forma-
tion and exploration of both unmet needs and socio-
emotional concerns [8]. This is crucial for building rap-
port and is associated with improvements in treatment
adherence, self-efficacy, and condition-related distress.
However, space-providing responses may warn of up-
coming unpleasant events, highlight unmet needs, and is
associated with reduced treatment satisfaction [9–12].
Because of aforementioned factors and consultations
rarely providing exclusively Affective or Cognitive
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reassurance, reassurance is complex [8–12]. It requires a
balance of providing sufficient space to voice concerns,
while also asking closed-ended questions and providing
space-reducing responses to sufficiently provide infor-
mation and facilitate a change in beliefs [13].
Reducing emotional distress is an increasing focus of
healthcare [14]. However, a limited evidence base is
present regarding the reassurance needs of people with
long-term conditions (LTC) in medical consultations
[15]. While reassurance is assumed to associate with im-
proved outcomes, parental expressions of empathy and
reassurance during children’s dental procedures were as-
sociated with increased distress and poorer procedural
outcomes [7, 16–18]. While this may potentially indicate
reassurance triggered negative emotions through warn-
ing of unpleasant events [19], it may also potentially re-
late to which of two mutually exclusive types of
reassurance was provided [20]. Affective reassurance in-
volves creating rapport and showing empathy to reduce
anxiety and enhance a sense of feeling understood. How-
ever, it may not empower people to develop new coping
mechanisms and is associated with mixed outcomes. For
example, improved satisfaction but negative effects on
disease-related burden, symptom improvement, and ad-
herence [1]. Conversely, Cognitive reassurance involves
educating and providing knowledge to systematically im-
pact beliefs. This approach may take longer and not have
immediate positive effects, but is consistently associated
with improved satisfaction, enablement and symptoms
[1]. Hence, consultations favouring Affective reassur-
ance are likely to be viewed as more empathic but Cog-
nitive have more positive outcomes.
Long-Term Conditions (LTC)
To understand the impact of reassurance on emotional
distress, it is crucial to evaluate whether and how clini-
cians both respond to emotional distress and spontan-
eously provide reassurance [21]. Previous studies have
assessed reassurance for emotional distress in settings
such as head and neck cancer [12] and oncology [22].
However, little is currently known about emotional dis-
tress and reassurance in people whose LTC at the time
of consultations are not actively curable and instead are
treated using active surveillance and/or symptom
management.
The pilot and feasibility study examined whether simi-
larities and differences are present between two LTC:
Huntington’s disease (HD) and prostate cancer (PC).
These LTC were selected as being potentially suitable
due to two primary factors. First, while there are signifi-
cant differences between LTC in terms of their cause,
presentation and treatment, for both people with HD (at
all condition stages) and PC (for specific individuals at
specific condition stages) curative treatment may not be
available and consequently treatment may take the form
of active surveillance and/or symptom management.
Second, in the geographic area where the pilot study was
conducted, strong links were present between the aca-
demic institution and the required relevant healthcare
organisations, increasing practicality and feasibility.
HD is a progressive, monogenic, neurodegenerative
disorder for which there is a 50% chance of passing HD
on to ones’ children. Symptoms typically present from
25 to 44 years-of-age and average survival is 15–20 years
post-onset [23–25]. HD progresses through five continu-
ous stages, increasingly affecting behavioural, psychiatric,
communicational, cognitive and sexual functioning [26,
27]. HD (currently) has no cure, and treatment involves
managing symptoms through pharmaceutical, psycho-
educational and/or neuropsychiatric treatments [25, 28–
30]. Critically, as suicide prevalence may be as high as
13%—seven-to-twelve times greater than the general
population [31]—understanding and managing emo-
tional distress for diagnosis, symptoms and disease pro-
gression is crucial for HD consultations.
PC is characterised by prostate cells growing in an un-
controlled way and may result in prostate enlargement
and urethra blockages [32]. PC is typically late-life onset
and may take decades to progress through four stages
from microscopic and undetectable, to affecting bones
and tissue. At specific stages of PC, radiotherapy and/or
surgery may be viable and necessary options. However,
active surveillance is currently the prescribed treatment
until such a time that symptoms and presentation indi-
cate this may occur [33]. During active surveillance,
people with PC may experience increased physiological
and psychological difficulties associated with unmet
needs including social support, coping and health-
related quality-of-life [34]. Furthermore, while self-
management is associated with improved functioning
and emotional wellbeing, self-management requires the
development of psychosocial strategies to reduce psy-
chological, sexual and relationship problems post-
diagnosis [35–37]. Hence, understanding and managing




It is unclear whether how people with long-term condi-
tions who are not currently suitable for curative treat-
ment express distress, and how clinicians respond,
influences perceptions of medical consultation out-
comes. The pilot and feasibility study conducted in 2015
aimed to explore consultations between clinicians and
people with LTC (specifically HD and PC) for which no
active treatment was (currently) available, and instead,
people with LTC were under active surveillance or
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symptom management. Specific objectives were to iden-
tify whether and how (1) people with LTC for whom
curative treatment is not currently the indicated ap-
proach expressed emotional distress, (2) clinicians’
responded, (3) clinicians’ spontaneously expressed re-
assurance, (4) clinicians’ utterances related to percep-
tions of empathy and consultation satisfaction, and (5)
differences were present between conditions.
A pilot and feasibility study was required and con-
ducted due to a number of factors. First, while increased
emphasis is being placed upon the importance of emo-
tional distress and reassurance in medical consultations,
there is currently a limited evidence base from which
larger-scale studies may develop upon. Second, afore-
mentioned studies typically focussed on individual LTC,
and little is known about the similarities and differences
in emotional distress and reassurance between different
LTC, particularly those for which active surveillance or
symptom management are the indicated treatment ap-
proach. Third, recruiting across different LTC popula-
tions and services can be challenging and an
understanding is required of whether coding of sessions
may receive buy-in from people with LTC and clinicians.
Finally, while coding of emotional distress and reassur-
ance has well defined methods, trialling these methods
in different LTC particularly those for whom speech
and/or physical disturbances may be present is import-
ant. Therefore, conducting a pilot and feasibility, rather
than a larger-scale initial trial was deemed a suitable,
feasible and practical approach to guide future research
and practice.
Participants
People with LTC and clinicians within a UK-based re-
gional national healthcare authority’s HD or PC services
were eligible. All participants were required to be aged
≥16 years old (legal age of capacity in Scotland (UK)),
speak English, have no severe mental difficulties, and be
physically and mentally able to consent. In order to bal-
ance potential HD communication difficulties with cod-
ing system requirements, provided people could verbally
communicate (regardless of speech disturbances), they
were eligible to participate. People with LTC were add-
itionally required to be undergoing active surveillance or
symptom management (not curative treatment). No fur-
ther exclusions applied.
One PC (100% male; 38 years old) and two HD clini-
cians (100% female; 50–51 years old), and 22 people
with LTC participated. Eleven people with HD encom-
passed 45% males, an average age of 41 years old (SD =
12), 45% undergoing active surveillance and 55% symp-
tom management, and 82% completed the Consultation
and Relational Empathy (CARE) measure [39, 40].
Eleven people with PC encompassed 100% males, an
average age of 69 years old (SD = 6), 100% undergoing
active surveillance, and 82% completed the CARE meas-
ure. Twenty-three consultations were audio or audio-
visual recorded, with one lost due to a technical mal-
function. Consultation average duration was 12 m41s
(SD = 3m49s), with PC averaging 7m30s (SD = 3m16s)
and HD 17m52s (SD = 1m8s).
Procedure
An observational pilot and feasibility study was con-
ducted involving consultations between people with
LTC and their respective clinician. The pilot study in-
volved audio-visual recordings (with audio recordings as
back-ups) of standard medical consultations. Recordings
were then coded for people with LTCs’ emotional dis-
tress expressions and clinicians’ responses. Effort was
made to avoid influencing consultations context, struc-
ture or content. Clinicians were contacted, provided with
information and invited to participate. Following in-
formed verbal consent, clinicians identified suitable
people with LTC to approach with information and an
invitation to participate. Prior to recording consultations,
the Principal Investigator (NA) provided information
sheets and obtained informed written consent from all
participants. The CARE measure [39, 40], with an add-
itional consultation satisfaction question, was provided
for voluntary completion and return using a pre-
stamped envelope. Recordings were securely transferred,
stored, transcribed, coded (NA), inter-rated coded (NA,
YZ) and analysed in a locked, password-protected coding
room and computer.
Measures
Observer XT 10.5® [41] was used to code 17 (11 HD, 6
PC), and five audio-only PC recordings (due to a camera
malfunction) were coded manually. Coding involved
three stages. First, people with LTCs’ emotional distress
verbal expressions were coded using validated Verona
Coding Definitions of Emotional Sequencing (VR-
CoDES) [42] (Table 1). As HD symptoms may include
abnormal motor movements, to ensure consistency ‘Cue
F’ was only coded for both conditions if crying/sobbing
was present. Second, clinicians’ responses to cues/con-
cerns were coded using validated VR-CoDES-of Provider
Responses (VR-CoDES-P) [43] (Table 2). Third, spon-
taneous clinician presentations of Cognitive and
Affective reassurance (in the absence of cues/concerns)
were coded (Table 2) [1, 2, 20]. Coding reliability was
tested, indicating ‘moderate’ intra-coder reliability (NA)
(range: 79–81%; κ = 0.75–0.76) and 'moderate'-to-
'strong' inter-coder reliability (NA; YZ) (range: 81–96%;
κ = 0.77–0.95) [44]. The CARE measure [39, 40] was
provided to generate a measure of people with LTCs’
ratings of empathy demonstrated by their clinician
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Table 1 Definitions and examples of patients’ expressions of emotional distress
Code Definitions Examples
Concern
'A clear and unambiguous expression of an
unpleasant emotion which was explicitly
verbalized.'
Emotional issue is recent or current "It was a huge worry for me."
Importance of the issue may or may not be stated "I was concerned by that."
Cue
'A verbal or non-verbal hint which suggests
underlying unpleasant emotions require
clarification."
(A) Vague or unspecified words or phrases used to describe one's
emotions which would require clarification
"I just try to cope with it every day."
(B) Non-explicit verbal hints towards one's hidden concerns "I hope it is only going to be
temporary."
(C) Verbal expressions emphasizing negative emotional states
regarding cognitive or physiological states
"I'll lie there and I'll have the alarm
going off an hour before I get up."
(D) Expressions referring to negative life events or conditions
using neutral content which emphasizes emotional importance of
issues and standards out from the narrative background
"I would say it's difficult, sometimes I
just don't know what I'm doing half
the time."
(E) Repeated expressions of previously neutral emotions “It has changed in the last fortnight,
but then maybe, because of the
medication…”
(F) Non-verbal expressions of negative or unpleasant emotions "I don't know... [Sobs]... it's hard."
(G) Clear and unambiguous negative emotional expression in
reference to the past (more than a month) or an unspecified
time-frame
"Being down, I've never been down,
you know, depressed, in my life like
that."








'Affect or content of the cue/concern
is not contained within the response'
Space-reducing














'Affect or content of the cue/concern
is contained within the response"
Space-reducing
















Spontaneous presentations (in the absence of patient cues/
concerns) which aim to create rapport and promote an empathetic
relationship
"I know, and you
would have been such
a good mum too."
Cognitive reassurance
'Information-advise'
Spontaneous presentations (in the absence of patient cues/
concerns) which aim to provide information and educate patients
in order to achieve changes in beliefs or understanding
"If the side effects are
too bothersome in the
morning, if you feel,
you know, quite
parched, quite dry with
the medication, stop it,
it'll be fine."
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during the consultation. Questions on the 10-question
CARE measure were scored on a five-point Likert scale
ranging from '1 - Poor' to '5 - Excellent'. This provided
individual scores for each question, and an overall per-
ceived empathy score of 10–50. A further question,
which asked 'Overall, how would you rate the consult-
ation?’ was also added using the same Likert scale to as-
sess overall consultation satisfaction.
Data analysis
Data was collated using Microsoft Office 2012 Excel™.
Analyses were conducted using SPSS Statistical Packages
22™. Response frequency differences between LTC were
assessed using t tests. For tests where the assumption of
homogeneity of variance was violated, Welch-
Satterthwaite adjustments were conducted. Pearson’s
correlations were calculated between all forms of clin-
ician responses and reassurance, and people with LTCs’
individual CARE measures [39, 40], overall CARE score
and satisfaction.
Results
Emotional distress and clinicians’ responses
On average (Table 3), people with LTC expressed 3.36
cues and 1.09 concerns per session, and clinicians
responded with 3.36 space-providing responses and 1.09
space-reducing responses utterances per session. Clini-
cians spontaneously provided 3.77 Cognitive and 1.5
Affective reassurance utterances per session. HD consul-
tations featured significantly more emotional distress
elicited by the person with LTC and their clinician, indi-
vidual cues A & D, overall cues, concerns and non-
explicit, explicit and space-providing responses to emo-
tional distress. However, HD consultations featured sig-
nificantly less cognitive and overall reassurance
responses.
Table 3 Patients’ and clinicians’ utterance frequencies (n = 22 consultations)









Patient emotional distress utterances Cue A 11 (85%) 2 (15%) 13 0.59 .33 (.14, 1.50)
Cue B 14 (64%) 8 (36%) 22 1.00 .45 (−.42, 1.51)
Cue C 6 (43%) 8 (57%) 14 0.64 .41 (−1.05, .68)
Cue D 5 (100%) 0 (100%) 5 0.23 .16 (.10, .81)
Cue E 0 (N/A) 0 (N/A) 0 0.00 N/A
Cue F 1 (100%) 0 (0%) 1 0.05 .09 (−.11, .29)
Cue G 15 (79%) 4 (21%) 19 0.86 .50 (−.07, 2.07)
Cue total 52 (70%) 22 (30%) 74 3.36 .86 (.88, 4.57)
Concern 19 (79%) 5 (21%) 24 1.09 .55 (.11, 2.44)
Patient-elicited 46 (69%) 21 (31%) 67 3.05 1.01 (.10,
4.44)
Clinician-elicited 25 (81%) 6 (19%) 31 1.41 .48 (.71, 2.74)
Cues/concerns
total
71 (72%) 27 (28%) 98 4.45 1.08 (1.74,
6.26)
Clinician emotional distress response
utterances
Non-explicit 31 (76%) 10 (24%) 41 1.86 .65 (.51, 3.31)
Explicit 40 (70%) 17 (30%) 57 2.59 .86 (.30, 3.88)
Space-providing 54 (73%) 20 (27%) 74 3.36 .92 (1.18,
5.00)
Space-reducing 17 (71%) 7 (29%) 24 1.09 .48 (−.09, 1.91)






11 (35%) 20 (65%) 31 1.5 .48 (−1.83, .19)
Cognitive
reassurance
32 (39%) 51 (61%) 83 3.77 .71 (−3.22,
−.23)
Reassurance total 43 (38%) 71 (62%) 114 5.18 .82 (−4.25,
−.84)
aFrequency: raw number (percent total frequency)
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Relationship between clinicians' responses and perceived
empathy and satisfaction
Eighty-two percent of participants (nine HD, nine PC)
completed the CARE measure [39, 40]. Participants
rated their clinician as 'Excellent' for 58%, ‘Very Good’
for 41%, and 'Good' for 1% of the 11 measures of per-
ceived empathy and satisfaction. Significant negative cor-
relations were present between Cognitive reassurance
and the individual CARE measures of 'Letting you tell
your story' (Estimate of comparison (95%) = .18 [[−.79,
[−.1]), 'Showing care and compassion' (Estimate of com-
parison (95%) = .16 [−.83, [−.24)], 'Helping you to take
control' (Estimate of comparison (95%) = .19 [[−.83,
[−.08]), and 'Making a plan of action with you' (Estimate
of comparison (95%) = .17 [[−.78, [−.1]). Non-significant
correlations were present between all individual CARE
measures, the overall CARE score, the overall satisfac-
tion score and all other measures.
Discussion
People with LTC emotional distress
Overall, people with LTC expressed 4.5 distress utter-
ances per consultations. However, how emotional dis-
tress was expressed varied considerable. 'Concern'
utterances are defined as 'Clear and unambiguous ex-
pressions of unpleasant emotions, whereas 'Cues' are de-
fined as 'Verbal or non-verbal hints suggesting
underlying unpleasant emotions which require clarifica-
tion'. When all forms of cues were combined, people
with LTC expressed over three-times as many cues
(3.36) as concerns (1.09) per consultation. However,
people with LTC expressed more clear and unambigu-
ous (concern) expressions of unpleasant emotions than
any individual cue. Furthermore, when people with LTC
did express a cue, this was most frequently through
'Non-explicit hints towards hidden concerns' (1.00),
'Negative emotional expressions in reference to the past'
(0.86), 'Verbal expressions of negative emotions regard-
ing physical or cognitive states' (0.64) or 'Vague or un-
specified utterances regarding ones' emotions' (0.59).
People with LTC rarely expressed emotional distress
through 'Negative life events through neutral content'
(0.23) or 'Non-verbal expressions of negative emotions'
(0.05), and never through 'Repeated expression of previ-
ously neutral emotions' (0.00).
The type and frequency of cues and concerns have im-
plications for understanding emotional distress in these
LTC populations. First, while consultations were primar-
ily conducted for health and medical needs, the high
levels of emotional distress supports the importance of
also accounting for emotional and psychological con-
cerns during consultations [45]. Additionally, as emo-
tional distress was twice as likely to be elicited by people
with LTC than clinicians, having the knowledge and
experience to reactively support and enable people with
LTC to cope with emotional distress should form a key
part of consultations and consequently clinician training
[14]. Second, approximately one concern being
expressed per session indicates people with LTC were
able to use sessions as an opportunity to express distress.
However, as over three times more cues were present
people with LTC were more likely to hint at concerns
rather than directly voicing them. From people with
LTC perspective, this may reflect experiencing emotional
distress but feeling unclear whether they can, should
and/or are able to reflect this in sessions. From clini-
cians’ perspective, as cues are hints, this may potentially
make distress more difficult to detect and respond to,
particularly if this is not the focus of consultations [46].
This may be supported by the most frequent clinician
responses being explicit and space-providing responses,
which may indicate a need to evoke further information
to seek clarification. Third, when people with LTC
expressed cues they rarely used non-verbal expressions
of negative emotions (one participant cried), and never
did so through repeatedly expressing previously neutral
content. Therefore, despite people with LTC preferring
to hint at concerns rather than directly expressing them,
they used a format that is verbally non-neutral which
may potentially increase the salience of the cue and in-
voke a response from clinicians.
While distress was high across participants, several
factors may have influenced why people with HD
expressed over twice as many overall, patient-elicited,
and clinician-elicited distress utterances than people
with PC per session. First, as HD consultations were on
average over twice as long (17m52s) as PC consultations
(7m30s), the additional time may have allowed greater
opportunity to express distress, explore topics further
and/or create rapport with clinicians. However, this pos-
sibility is reduced by both samples demonstrating emo-
tional distress more frequently towards the beginning of
consultations. Second, in addition to overall emotional
distress, people with HD expressed significantly more
concerns, overall cues, 'Vague or unspecified utterances
regarding ones' emotions' and 'Negative life events
through neutral content' utterances. While both condi-
tions are associated with significant challenges for
quality-of-life, the increased focus on negative life events
may relate to the progressive, neuro-degenerative nature
of HD. In particular, this may potentially indicate disin-
hibited behaviour relating to neurological and personal-
ity changes or potential implications for genetic
transmission [23]. Third, emotional distress differences
may potentially relate to differences in consultation
focus, content or clinician style, such as clinicians' re-
sponses to emotional distress and spontaneous use of
empathy. Therefore, future research is required to
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understand the mechanisms behind the high levels of
emotional distress in people with LTC, distress typically
being expressed using hints rather than directly voicing
concerns and between LTC differences.
Clinicians’ reassurance
Overall, clinicians expressed 5.18 spontaneous reassur-
ance utterances per consultation. While consultations
were primarily conducted for medical difficulties, this
also demonstrates clinicians used them as critical oppor-
tunities to reassure people with LTC about emotional
distress rather than focusing purely on medical issues.
Previous research [47] demonstrated in breast cancer
consultations clinicians undergo different cognitive
states during which they are more likely to use a specific
type of reassurance and less likely to switch types. This
also appeared to be reflected in this pilot study as spon-
taneous reassurance was more than twice as likely to be
expressed through Cognitive (3.77) utterances which
'aim to provide information and educate patients in
order to achieve changes in beliefs or understanding',
than it was to be through Affective (1.5) utterances
which 'aim to create rapport and promote and empath-
etic relationship'. The preference for Cognitive reassur-
ance to systematically provide information contrasted
with how clinicians responded to emotional distress,
which was more frequently through Explicit (2.59) and/
or space-providing responses (3.36) to seek expansion
upon affect relating to distress, than Non-Explicit (1.86)
and/or space-reducing responses (1.09) to provide infor-
mation and change beliefs.
Future research is required to explore the potential
factors that may have influenced why consultations dem-
onstrated greater levels of Cognitive than Affective re-
assurance, and spontaneous reassurance than responses
to emotional distress. First, as more space-providing
than space-reducing responses were present, clinicians
may potentially seek to explore distress further to in-
crease their understanding of difficulties, before then
providing reassurance if/when deemed necessary. In
other words, this may potentially be a response to people
with LTC expressing more hints (cues) than concerns,
resulting in clinicians seeking expansion before deciding
how to respond. Second, reassurance may be used to
pre-emptively managing and helping people with LTC
to cope with distress before they feel the need to express
it. As reassurance most frequently occurred towards the
beginning of consultations in Cognitive form, this may
mean that clinicians seek to provide spontaneous re-
assurance early as a pre-emptive attempt to reduce dis-
tress. Third, clinicians may frequently not perceive
emotional distress utterances as being salient and so
await content indicating reassurance is required [48].
Clinicians of both LTC expressed more Cognitive than
Affective reassurance. However, HD clinicians expressed
nearly half as many Affective and two thirds as many
Cognitive reassurance utterances as PC clinicians. Future
research is required to develop upon pilot findings and
examine whether this relates to aforementioned
between-LTC differences influencing needs and conse-
quently clinician responses, or whether further possible
explanations are present, as this may have implications
for practice.
As all people with PC were undergoing active surveil-
lance, clinicians may potentially have provided high
levels of Affective reassurance to create rapport and
Cognitive reassurance to provide disease-related infor-
mation in previous appointments. Conversely, people
with HD were at different condition and service involve-
ment stages, the prevalence of HD in the general popu-
lation is lower than PC, and consequently HD clinicians
may have had greater capacity/remit to have increased
involvement (indicated by greater session durations).
This may have been associated with increased opportun-
ity to develop rapport and consequently HD clinicians
perceiving increased self-efficacy to focus more on Cog-
nitive reassurance and/or tailoring their reassurance ap-
proach to individuals’ needs. Furthermore, as people
with HD demonstrated more emotional distress utter-
ances than people with PC, this may have provided
greater opportunity to respond to the issue directly and
reduced reassurance needs. Whereas for PC consulta-
tions where the frequency of emotional distress was lim-
ited, spontaneous reassurance may have been used to
compensate. Therefore, future research should seek to
examine the links between emotional distress and spon-
taneous reassurance, including whether factors associ-
ated with specific LTC and services influences needs and
responses.
Based on previous research, it would be expected that
consultations demonstrating higher levels of Cognitive
reassurance would result in higher levels of satisfaction
[13], while those with higher levels of Affective reassur-
ance would result in higher levels of perceived empathy
[11]. Overall, no correlation was present between
Affective or Cognitive reassurance and satisfaction.
However, while no correlations were present between
Affective reassurance and any empathy measure, higher
Cognitive reassurance was significantly associated with
lower scores for 'Letting you tell your story' , 'Showing
care and compassion' , 'Helping you to take control' and
'Making a plan of action with you'. This could potentially
indicate that, while Cognitive reassurance serves the pur-
pose of providing information with a view to reduce dis-
tress and change beliefs, providing more utterances may
be perceived as less empathetic. Conversely, due to LTC
symptoms, diagnosis and symptom management having
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significant physical, psychological and social burden, it
may potentially be that Cognitive reassurance involves
the provision of necessary but challenging information
to process and consequently is not perceived as empath-
etic. However, as 99.49% of measures were scored as
'Very Good' or 'Excellent', reassurance formed a crucial
part of consultations and future research would benefit
from exploring the optimal reassurance approach.
Pilot study strengths and limitations
To the researchers' knowledge, the pilot and feasibility
study was the first to explore clinician management of
emotional distress specifically in people with LTC where
no treatment was available and instead were undergoing
active surveillance or symptom management. The pilot
study benefitted from all recruited people with LTC
completing their medical consultation and 82% return-
ing their CARE measure. Additionally, all clinicians vol-
untarily agreed to participate and actively engaged in
recruiting participants. This indicates that both clini-
cians and people of these LTC populations and services,
for whom active surveillance or symptom management
was the only (current) option available, were highly in-
terested and engaged in research with potential implica-
tions for care. Additionally as moderate intra-rater and
moderate-to-strong inter-rater reliability was present,
the people with LTC and clinician codes and results can
be stated with a reasonable degree of certainty. Further-
more, rather than merely assessing whether emotional
distress or reassurance was present in consultations, the
pilot study also assessed the form that distress was
expressed in how clinicians responded and how this re-
lates to spontaneous reassurance. Finally, the pilot study
assessed how spontaneous reassurance related to people
with LTCs’ perceptions of clinician empathy and con-
sultation satisfaction. Therefore, the methodology used
allowed for in-depth assessment of consultation interac-
tions and provides valuable findings with real-world im-
plications for healthcare policy, practice and training.
The pilot and feasibility study featured two study sites,
two LTC populations, three clinician and 22 people with
LTC participants. This was deemed practical for a pilot
and feasibility study, and the populations and settings
targeted were both accessible and viewed as priorities
for the UK-based regional national healthcare authority.
However, a number of limitations (which are common
findings of pilot and feasibility studies) were present
which must be accounted for and developed upon in fu-
ture, larger-scale studies. First, while clinicians offering
participation to people with LTC within their clinics was
deemed an appropriate and suitable approach for facili-
tating participation by a trusted and knowledgeable
source, this raises the possibility of a recruitment bias.
Second, in terms of the participants recruited, multiple
confounding factors may have influenced outcomes in-
cluding the gender and average age of people with LTC
(HD: 55% female; 41 years old; PC: 0% female, 69 years
old) and clinicians (HD: 100% female, 50–51 years old;
PC: 0% female, 38 years old), current treatment (HD:
45% active surveillance; PC 100% active surveillance)
and average session duration (HD: 17m52s; PC: 7m30s).
Additionally, a number of statistical tests were con-
ducted with a limited sample size. Therefore, future
studies would benefit from an increased sample size of
people with LTC and clinicians, and the inclusion of a
control condition, such as a previously explored area of
reassurance research or check-up appointments which
reveal no diagnosis, in order to increase the reliability of
findings and make valid comparisons.
Several implications are present from the pilot and
feasibility study utilizing the validated VR-CoDES, VR-
CoDES-P and CARE measures [38, 40–43]. First, while
the CARE measure is widely used in healthcare research,
the addition of a satisfaction question may not have been
sufficient to detect effects and future research would
benefit from the development of a more expansive ques-
tionnaire. Second, the Observer XT® system provided a
systematic method for assessing audio-visual observa-
tions. However, unfortunately visual data was lost for
five of 22 recordings, and as the system did not allow for
audio-only files, these were coded manually without vis-
ual data being detected.
The pilot study was conducted in 2014–2015 using
VR-CoDES. VR-CoDES are used as a validated measure
for assessing emotion distress across multiple domains
[12, 18, 41, 42]. While the action-response criteria uti-
lised was beneficial for exploring potential bi-direction
relationships in people with LTC-clinician interactions,
it did not originally account for the occurrence of poten-
tially important information that may influence emo-
tional distress or implications for subsequent codes.
However, research has since explored how VR-CoDES
may be used to conduct analysis of longer sequences of
codes to negate this confound [47, 49, 50]. In the future,
researchers may wish to consider the sequence of events
when using a form of reassurance to understand the
presentation of distress in the form of cues or concerns,
and types of reassurance, in order to further understand
and assist the development of theoretical models for
testing [47]. Therefore, future replications are required
which utilize pilot and feasibility study strengths,
minimize limitations, and factor in subsequent research
advancements.
Conclusion
To the authors’ knowledge, the pilot study was the first
to examine emotional distress and reassurance in med-
ical consultations with people with LTC for whom active
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surveillance or symptom management was the indicated
approach. The pilot study demonstrated actively en-
gaging clinicians and people with LTC in healthcare-
focussed research may enhance the understanding of
both interactions and self-rated outcomes of sessions.
The pilot study highlighted the importance of under-
standing emotional distress, clinicians’ responses and re-
assurance in consultations and may indicate that a ‘one-
size-fits-all’ approach to research and LTC management
may not account for nuanced differences between LTC.
Future large-scale studies are required which develop
upon pilot findings and recommendations, and incorpor-
ate subsequent research developments, with larger par-
ticipant samples and variability.
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